Duplex Oligonucleotides Mismatched Sense Strands

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Chemical modifications added to the sense strand of duplex oligonucleotides, such as 2′-O-methyl modifications, can enhance stability but also have negative effects on their functionality, particularly by acting as miRNA inhibitors, limiting the function of miRNA mimics.

Innovation Solution

Incorporating specific mismatches at distinct positions within the duplex oligonucleotide, such as between nucleotides 1, 7, and 14, minimizes these negative effects by preventing the sense strand from inhibiting the action of the antisense strand, thus maintaining or enhancing the functionality of the miRNA mimics.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Stability of the object's composition

If chemical modifications such as 2′-O-methyl groups are added to the sense strand to enhance stability, then nuclease resistance is improved, but the sense strand begins to act as a miRNA inhibitor, reducing the functionality of the duplex oligonucleotide

Engineering Contradiction:
Improvenuclease resistanceVSAvoidmiRNA inhibition
Core Design Contradiction:
Stability of the object's compositionVSObject-generated harmful factors

Solution Approach 1:

The patent removes the problematic sense strand from the duplex structure by introducing mismatches that prevent it from functioning, while preserving the stable modified sense strand's resistance to nucleases. The mismatches effectively extract the harmful inhibitory function while retaining the beneficial stability.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent converts the harmful effect of the modified sense strand acting as a miRNA inhibitor into a beneficial design feature. By strategically placing mismatches, the sense strand's modified nucleotides provide nuclease resistance while the mismatches prevent inhibitory activity, turning a potential harm into a controlled feature.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

2Duration of action of stationary object

If chemical modifications are added to enhance stability and binding affinity, then the oligonucleotide becomes more resistant to degradation, but the overall functionality is reduced due to sense strand inhibition

Engineering Contradiction:
Improveoligonucleotide stabilityVSAvoidgene silencing efficiency
Core Design Contradiction:
Duration of action of stationary objectVSProductivity

Solution Approach 1:

The patent applies local quality by modifying only specific nucleotides in the sense strand (40-90% modification) rather than the entire strand, and by placing mismatches at specific positions. This localized approach maintains stability where modifications are present while preserving functionality in regions where mismatches prevent inhibitory activity.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent changes the structural parameters of the duplex by introducing mismatches at specific positions (nucleotide 1, 7, or 14 of the antisense strand). This parameter change disrupts the sense strand's ability to inhibit miRNA function while maintaining the stabilizing effect of the chemical modifications on the overall structure.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If the sense strand is highly stable due to chemical modifications, then it resists degradation, but it competes with the antisense strand for RISC loading, reducing gene silencing activity

Engineering Contradiction:
Improvestrand stabilityVSAvoidRISC loading interference
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent applies preliminary anti-action by introducing mismatches in advance that specifically prevent the stable modified sense strand from loading into RISC and inhibiting miRNA function. The mismatches are positioned to block sense strand activity before it can interfere with the antisense strand's gene silencing function.

Inventive Principle:
Principle #9Preliminary anti-action

Data Source

PatentUS8415466B2Duplex oligonucleotides with enhanced functionality in gene regulation
Publication Date: 2013.04.09 DHARMACON INC
  • US8415466B2 patent drawing
  • US8415466B2 patent drawing
  • US8415466B2 patent drawing

AI summary

Disclosed are methods of enhancing functionality of duplex oligonucleotides and compositions made by the methods. The duplex oligonucleotides include siRNAs, miRNA mimics, and piRNA mimics which contain modified nucleotides and mismatches between the two strands of the molecule at specific nucleotide positions.